pharmacy-benefits managers Trapelo Health, Magellan Hope to Ease Prior Authorization for Precision Oncology Testing Premium The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions. Trapelo Health, Magellan Rx Team on Value-Based Precision Oncology The technology vendor and the PBM will offer a bundled platform to help guide cancer patients to the most appropriate treatments. Kroger Prescription Plans to Offer Myriad Genetics' Vectra DA as Benefit Option According to Myriad, a similar deal is in the works with the pharmacy benefit management services provider for its GeneSight pharmacogenetic test. Buying Remaining Stake in Generation Health, CVS Caremark Keeps PGx Programs but Cuts Staff Premium Originally published Aug. 23. New Firm MetaDiagnostic Moves in to Help Dx Developers, Payors as PBMs Shift from Personalized Rx Premium Originally published Aug. 27. Jul 27, 2011 Fate of Medco's Personalized Medicine Programs Uncertain Under Express Scripts' Acquisition Plan Premium Feb 9, 2011 Medco Funds Pharmacy School at Fairleigh Dickinson University with Personalized Rx Focus Premium Nov 10, 2010 Doctor, Patient Adoption of PGx Testing Increases in PBM-Initiated Programs, Medco Reports at ASHG Premium Jun 2, 2010 CVS Caremark, Generation Health Unveil 13 Drugs for PGx Testing Program, But Not Warfarin Premium Oct 21, 2009 Generation Health Emulates the PBM Model to Optimize Genetic Testing for Payors Premium Mar 26, 2009 Comparative Effectiveness Research Begins with $1B from Stimulus Breaking News Plasmid Transfer Let Cholera Pathogen in Yemen Become Multidrug Resistant, Study Suggests Harbinger Health Raises $140 Million in Series B Financing BioMérieux's BioFire Defense Secures $18.8M US DoD Contract for Infectious Disease Testing Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.